Patterns of progression in patients (pts) with V600 BRAF-mutated melanoma metastatic to the brain treated with dabrafenib (GSK2118436).
Mary W. F. Azer
No relevant relationships to disclose
Alexander M. Menzies
No relevant relationships to disclose
Lauren Haydu
No relevant relationships to disclose
Richard Kefford
Consultant or Advisory Role - GlaxoSmithKline
Georgina V. Long
Consultant or Advisory Role - GlaxoSmithKline
Other Remuneration - GlaxoSmithKline